2 news items
Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors
NKTX
13 Jun 24
Nkarta's Board; Nkarta's position, plans, and strategies for the continued and future clinical development and commercial potential of its product
enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors
NKTX
15 May 24
and divestment strategies, and focuses on Forbion's Growth Opportunities Funds, which concentrates on investing in late-stage life sciences companies
- Prev
- 1
- Next